Skip to main content
. 2018 Feb 6;11(1):16. doi: 10.3390/ph11010016

Table 2.

Comparison of GI50 of gemcitabine, NUC050 and NUC024 in the presence or absence of dipyridamole (DP).

GI50 (μM)
Breast MDA-MB-231 Non-Small Cell Lung NCI-H460 Colon HCT116
Compound DP (−) DP (20 μM) DP (−) DP (20 μM) DP (−) DP (20 μM)
Gemcitabine 3.08 56.77 0.02 0.82 0.03 2.39
NUC050 17.16 23.30 2.14 1.47 3.07 6.74
NUC024 30.34 27.77 7.16 15.98 5.55 12.61